Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women;Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non-in feriority'-studie bij post men opauzale vrouwen

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 10, 2013, Pages

  Beerepoot, Mariëlle A J ^a   Ter Riet, Gerben ^a   Nys, Sita ^b   Van Der Wal, Willem M ^c   De Borgie, Corianne A J M ^a   De Reijke, Theo M ^a   Prins, Jan M ^a   Koeijers, Jeanne ^b   Verbon, Annelies ^d   Stobberingh, Ellen E ^b   Geerlings, Suzanne E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; COTRIMOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; FEMALE; HUMAN; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; URINARY TRACT INFECTION;

EID: 84876374284     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Van Geelen JM, van de Weijer PH, Arnolds HT. Urogenitale verschijnselen en hinder daarvan bij thuiswonende Nederlandse vrouwen van 50 tot 75 jaar. Ned Tijdschr Geneeskd. 1996;140:713-6.
2. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259-68.
3. Hoogkamp-Korstanje JA, Mouton JW, van der Bij AK, de Neeling AJ, Mevius DJ, Koene MG. Nethmap 2012. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. www.swab.nl/NethMap, geraadpleegd op 9 december 2012.
4. Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal fora alterations in postmenopausal women. J Infect Dis. 2003;188:1054-8.
5. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 signifcantly alters vaginal fora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35:131-4.
6. Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am. 2008;35:13-22.
7. Liu YC, Huang WK, Huang TS, Kunin CM. Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use. J Clin Epidemiol. 1999;52:539-45.
8. Haarman M, Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2006;72:2359-65.
9. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
10. Little P, Turner S, Rumsby K, et al. Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specifcity of near patient tests (dipsticks) and clinical scores. Br J Gen Pract. 2006;56:606-12.
11. Soonawala D, Dekkers OM. 'Non-inferiority'-studies: mogelijkheden en kanttekeningen. Ned Tijdschr Geneeskd. 2012;156:A4665.
12. Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med. 1982;306:130-5.
13. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 2003;52:128-31.
14. Reid G, Bruce AW, Taylor M. Infuence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ter. 1992;14:11-6.
15. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52:1212-7.
16. Reid G. BATM. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ter 1995;32-45.
17. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol. 2004;38:S107-10.
18. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal fora. FEMS Immunol Med Microbiol. 2001;32:37-41.
19. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30:49-52.
20. Bent S, Saint S. Te optimal use of diagnostic testing in women with acute uncomplicated cystitis. Dis Mon. 2003;49:83-98.
21. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20.